(주)이앤에스헬스케어

  • 1 Kim, Y. (2022, July). Clinical Evaluation of Thioredoxin 1 in the Blood as a Novel Biomarker to Detect Breast Cancer. Poster presented at American Association for Clinical Chemistry annual scientific meeting & Clinical Lab Expo, Chicago, IL, U.S., Abstract retrieved from https://meeting.aacc.org/-/media/Files/Meetings-and-Events/Annual-Meeting/2022/AACC22_AbstractBook_Final.pdf?la=en&hash=B978AA002D9D9DE1E12185BCB2CCB3861302F210
  • 2 Lee, Y.J., Kim, Y., Choi, B.B., Kim, J.R., Ko, H.M. Suh, K.H. & Lee, J.S. (2022). The blood level of thioredoxin 1 as a supporting biomarker in the detection of breast cancer. BMC Cancer, 22:12
  • 3 Ko. H.M. (2022, April). The Blood Level of Thioredoxin 1 as a Biomarker for the Monitoring of Breast Cancer Patients Underwent Surgery. Poster presented at Global Breast Cancer Conference, Seoul, KR, Abstract retrieved from http://gbcc.kr/upload/GBCC%202022_Announcement.pdf

(한국유방암학회 2020)

팝업 닫기